本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

196.94
+1.020.52%
盤後195.95-0.9900-0.50%18:11 EDT
成交量:182.08萬
成交額:3.61億
市值:422.11億
市盈率:-22.08
高:202.02
開:198.53
低:194.80
收:195.92
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:1.17
換手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.20
市盈率(LYR):-33.10

資料載入中...

2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report